Search

everythinglearnresearchcommunity

for

Search:↓

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.

Androgenetic alopecia, a genetic disorder affecting up to 50% of adults, is caused by an excessive response to androgens leading to hair follicle shrinkage. Treatments include FDA-approved drugs, other therapies like low-dose oral minoxidil, and hair transplantation.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

Diagnose and manage CCCA with thorough history, exams, and labs; treat with anti-inflammatory agents, stress reduction, and stopping harmful hair practices.

Targeting Vδ1+T-cells may help treat alopecia areata.

Terminalia bellirica extracts effectively promote hair regrowth and treat androgenetic alopecia.

Antioxidant-rich diets may reduce hair loss risk, while pro-inflammatory diets may increase it, especially in women.

Different types of male pattern baldness have unique inflammation-related protein patterns.

A rare skin condition was misdiagnosed as a harmless mole on a woman's eyelid.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

RCM and OCT are effective for diagnosing and monitoring hair-related skin diseases but lack standardized protocols and need more research.

Platelet-rich plasma therapy may help treat folliculitis decalvans but benefits might not last without ongoing treatment.

Lichen planopilaris is the most common type of scarring hair loss observed, with a variety of symptoms and tissue changes.

Hyaluronic acid successfully treated skin atrophy caused by corticosteroid injections.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition with inflammation and scarring, resembling but distinct from common balding.

VEGF helps hair grow and determines follicle size by increasing blood vessel growth.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Intense pulsed light (IPL) is an efficient and safe method for hair removal, reducing hair by about 80%.

Oral isotretinoin effectively treats yellow facial papules in frontal fibrosing alopecia patients.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

CCCA is a common, progressive hair loss condition that may not always be linked to hair care practices and requires a biopsy for diagnosis.

New LPP subtype affects vellus hairs, mimics AGA, and needs biopsy for diagnosis.

Recognize and treat hair loss conditions that mimic androgenetic alopecia by identifying warning signs and using proper tools.

The document concludes that treatment can improve hair growth and symptoms in Fibrosing Alopecia in a Pattern Distribution.

A rare skin condition called linear lichen planopilaris caused itchy red bumps and hair loss on a man's face.